High Resolution Screening of Plant Natural Product Extracts for Estrogen Receptor a and f3 Binding Activity Using an Online HPLC-MS Biochemical Detection System
Free accessResearch articleFirst published online October, 2001
High Resolution Screening of Plant Natural Product Extracts for Estrogen Receptor a and f3 Binding Activity Using an Online HPLC-MS Biochemical Detection System
A new screening technology that combines biochemical analysis with the resolution power of high-performance liquid chromatography (HPLC), referred to here as high-resolution screening (HRS) technique, is described. The capability of the HRS technology to analyze biologically active compounds in complex mixtures is demonstrated by screening a plant natural product extract library for estrogen receptor (ER) a and fi binding activity. The simultaneous structure elucidation of biologically active components in crude extracts was achieved by operating the HRS system in combination with mass spectrometry (MS). In contrast to conventional microtiter-type bioassays, the interactions of the extracts with the ER and the employed label, coumestrol, proceeded at high speed in a closed, continuous-flow reaction detection system, which was coupled directly to the outlet of a HPLC separation column. The reaction products of this homogeneous fluorescence enhancement-type assay were detected online using a flow-through fluorescence detector. Primary screening of the extract library was performed in the fast-flow injection analysis mode (FlowScreening) wherein the chromatographic separation system was bypassed. The library was screened at high speed, using two assay lines in parallel. A total of 98% of the identified hits were confirmed in a traditional 96-well microplate-based fluorescence polarization assay, indicating the reliability of the FlowScreening process. Active extracts were reassayed in a transcriptional activation assay in order to assess the functional activity of the bioactive extracts. Only functional active extracts were processed in the more time-consuming HRS mode, which was operated in combination with MS. Information on the number of active compounds, their retention times, the molecular masses, and the MS/MS-fingerprints as a function of their biological activity was obtained from 50% of the functional active extracts in real time. This dramatically enhances the speed of biologically active compound characterization in natural product extracts compared to traditional fractionation approaches.
References
1.
Grady D, Rubin SM, Petitti DB, et al: Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med1992;117:1016-1037.
2.
The Writing Group for the PEPI Trial: Effects of hormone therapy on bone mineral density: results from the Postmenopausal Estrogen/Progestin Interventions (PEPI) trial. JAMA1996;276:1389-1396.
3.
Cauley JA, Seeley DG, Ensrud K, et al: Estrogen replacement therapy and fractures in older women. Ann Intern Med1995;122:9-16.
4.
Pickar JH, Thorneycroft I, Whitehead M: Effects of hormone replacement therapy on the endometrium and lipid parameters: a review of randomized clinical trials, 1985-1995. Am J Obstet Gynecol1998;178:1087-1099.
5.
Ettinger B, Pressman A, Silver P: Effect of age for initiation and discontinuation of hormone replacement therapy. Menopause1999;6:282-289.
Setchell KDR, Cassidy A: Dietary isoflavones: biological effects and relevance to human health. J Nutr1999;129:758S-767S.
8.
Kurzer MS, Xu X: Dietary phytoestrogens. Annu Rev Nutr1997;17:353-381.
9.
Kuiper GGJM, Lemmen JG, Carlsson B, et al: Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology1998;139:4252-4263.
10.
Hook DJ, Pack EJ, Yacobucci JJ, et al: Approaches to automating the dereplication of bioactive natural products—the key step in high throughput screening of bioactive materials from natural sources. J Biomol Screen1997;2:145-152.
11.
Wolfender J-L, Rodriguez S, Hostettmann K: Liquid chromatography coupled to mass spectrometry and nuclear magnetic resonance spectroscopy for the screening of plant constituents. J Chromatogr A1998;794:299-316.
12.
Corley DG, Durley RC: Strategies for database dereplication of natural products. J Nat Prod1994;57:1484-1490.
13.
Wolfender J-L, Rodriguez S, Hostettmann K, et al: Comparison of liquid chromatography electrospray, atmospheric pressure chemical ionization, thermospray and continuous-flow fast atom bombardment mass spectrometry for the determination of secondary metabolites in crude plant extracts. J Mass Spectrom1995;Suppl S:S35-S36.
14.
Shigematsu N: Dereplication of natural products using LCIMS. J Mass Spectrom Soc Jpn1997;45:295-300.
15.
Pannell LK, Shigematsu N: Increased speed and accuracy of structural determination of natural products using LC-MS. Am Lab1998;30:28-30.
16.
Oosterkamp AJ, Villaverde Herraiz MT, Irth H, et al: Reversed-phase liquid chromatography coupled online to receptor affinity detection based on the human estrogen receptor. Anal Chem1996;68:1201-1206.
17.
Dudley RA, Edwards P, Ekins RP, et al: Guidelines for immunoassay data processing. Clin Chem1985;31:1264-1271.
18.
Nelson K, Pavlik EJ, van Nagell Jr JR, et al: Estrogenicity of coumestrol in the mouse: fluorescence detection of interaction with estrogen receptors. Biochemistry1984;23:2565-2572.
19.
Parker GJ, Law TL, Lenoch FJ, et al: Development of high throughput screening assays using fluorescence polarization: nuclear receptor-ligand-binding and kinase/phosphatase assays. J Biomol Screen2000;5:77-88.
20.
Long GL, Winefordner JD: Limit of detection: a closer look at the IUPAC definition. Anal Chem1983;55:712A-724A.
21.
Bolger R, Wiese TE, Ervin K, et al: Rapid screening of environmental chemicals for estrogen receptor binding capacity. Envir Health Perspect1998;106:551-557.
22.
Arts CJM, Van den Berg H: Multi-residue screening of bovine urine on xenobiotic oestrogens with an oestrogen radioreceptor assay. J Chromatogr1989;489:225-234.
23.
Zhang J-H, Chung TDY, Oldenburg KR: A simple statistical parameter for use in evaluation and validation of high throughput assays. J Biomol Screen1999;4:67-73.
24.
Jodlbauer J, Zollner P, Lindner W: Determination of zeranol, taleranol, zearalenone, alpha- and beta-zearalenol in urine and tissue by high-performance liquid chromatography-tandem mass spectrometry. Chromatographia2000;51:681-687.
